Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: Takeda Pharmaceutical, FRN 6jun2079, JPY (00014502, JP346300AK65)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard
PDF download
Choose all Reset all
Download Cancel
Add issue to Watchlist
Choose all Reset all
{{ watchlistErrorMsg }}
Save Collapse
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.

Variable rate, Subordinated Unsecured

Status
Outstanding
Amount
500,000,000,000 JPY
Placement
***
Redemption (put/call option)
*** (-)
ACI on
Country of risk
Japan
Current coupon
***%
Price
-
Yield / Duration
-
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
  • Placement amount
    500,000,000,000 JPY
  • Outstanding amount
    500,000,000,000 JPY
  • USD equivalent
    3,238,352,455.8 USD
  • Face value
    100,000,000 JPY
  • ISIN
    JP346300AK65
  • CFI
    DBVUFB
  • FIGI
    BBG00NBNYL57
  • Ticker
    TACHEM V1.72 06/06/79 1

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Quotes provided by information providers are indicative in nature

Issue information

Profile
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in ...
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.
Show more Hide
Volume
  • Placement amount
    500,000,000,000 JPY
  • Outstanding amount
    500,000,000,000 JPY
  • Outstanding face value amount
    500,000,000,000 JPY
  • USD equivalent
    3,238,352,456 USD
Face value
  • Face value
    100,000,000 JPY
  • Outstanding face value
    *** JPY
  • Increment
    *** JPY

Cash flow parameters

  • Variable rate type
    Fix to Float
  • Reference rate
    6M LIBOR JPY
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Bookrunner
    ***
  • Depository
    ***
  • Paying agent
    ***

Conversion and exchange

  • Conversion terms
    ***

Additional information

Latest issues

Show all

News

16/04/2024 S&P Global Ratings affirms Takeda Pharmaceutical at "BBB+" (Foreign Currency LT credit rating); outlook stable
16/04/2024 S&P Global Ratings affirms Takeda Pharmaceutical at "BBB+" (Local Currency LT credit rating); outlook stable
31/07/2023 S&P Global Ratings affirms Takeda Pharmaceutical at "BBB+" (Foreign Currency LT credit rating); outlook stable
31/07/2023 S&P Global Ratings affirms Takeda Pharmaceutical at "BBB+" (Local Currency LT credit rating); outlook stable
27/06/2023 Moody's Investors Service upgrades LT- local currency credit rating of Takeda Pharmaceutical to "Baa1" from "Baa2"
All organization news

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Identifiers

  • State registration number
    00014502
  • ISIN
    JP346300AK65
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBVUFB
  • FIGI
    BBG00NBNYL57
  • Ticker
    TACHEM V1.72 06/06/79 1
  • Type of security by CBR
    ***

Bond classification

  • Subordinated Unsecured
  • Coupon bonds
  • Bearer
  • Variable rate
  • Subordinated
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Registration is required to get access.